448 related articles for article (PubMed ID: 12202832)
1. Medulloblastoma growth inhibition by hedgehog pathway blockade.
Berman DM; Karhadkar SS; Hallahan AR; Pritchard JI; Eberhart CG; Watkins DN; Chen JK; Cooper MK; Taipale J; Olson JM; Beachy PA
Science; 2002 Aug; 297(5586):1559-61. PubMed ID: 12202832
[TBL] [Abstract][Full Text] [Related]
2. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours.
Berman DM; Karhadkar SS; Maitra A; Montes De Oca R; Gerstenblith MR; Briggs K; Parker AR; Shimada Y; Eshleman JR; Watkins DN; Beachy PA
Nature; 2003 Oct; 425(6960):846-51. PubMed ID: 14520411
[TBL] [Abstract][Full Text] [Related]
3. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449.
Rudin CM; Hann CL; Laterra J; Yauch RL; Callahan CA; Fu L; Holcomb T; Stinson J; Gould SE; Coleman B; LoRusso PM; Von Hoff DD; de Sauvage FJ; Low JA
N Engl J Med; 2009 Sep; 361(12):1173-8. PubMed ID: 19726761
[TBL] [Abstract][Full Text] [Related]
4. PTEN loss mitigates the response of medulloblastoma to Hedgehog pathway inhibition.
Metcalfe C; Alicke B; Crow A; Lamoureux M; Dijkgraaf GJ; Peale F; Gould SE; de Sauvage FJ
Cancer Res; 2013 Dec; 73(23):7034-42. PubMed ID: 24154871
[TBL] [Abstract][Full Text] [Related]
5. Shh pathway activity is down-regulated in cultured medulloblastoma cells: implications for preclinical studies.
Sasai K; Romer JT; Lee Y; Finkelstein D; Fuller C; McKinnon PJ; Curran T
Cancer Res; 2006 Apr; 66(8):4215-22. PubMed ID: 16618744
[TBL] [Abstract][Full Text] [Related]
6. Statins Synergize with Hedgehog Pathway Inhibitors for Treatment of Medulloblastoma.
Gordon RE; Zhang L; Peri S; Kuo YM; Du F; Egleston BL; Ng JMY; Andrews AJ; Astsaturov I; Curran T; Yang ZJ
Clin Cancer Res; 2018 Mar; 24(6):1375-1388. PubMed ID: 29437795
[No Abstract] [Full Text] [Related]
7. Two-hit model for progression of medulloblastoma preneoplasia in Patched heterozygous mice.
Pazzaglia S; Tanori M; Mancuso M; Gessi M; Pasquali E; Leonardi S; Oliva MA; Rebessi S; Di Majo V; Covelli V; Giangaspero F; Saran A
Oncogene; 2006 Sep; 25(40):5575-80. PubMed ID: 16636673
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications of hedgehog signaling pathway inhibitors.
Liu H; Gu D; Xie J
Chin J Cancer; 2011 Jan; 30(1):13-26. PubMed ID: 21192841
[TBL] [Abstract][Full Text] [Related]
9. Identification of pseudolaric acid B as a novel Hedgehog pathway inhibitor in medulloblastoma.
Wei SF; He DH; Zhang SB; Lu Y; Ye X; Fan XZ; Wang H; Wang Q; Liu YQ
Biochem Pharmacol; 2021 Aug; 190():114593. PubMed ID: 33964282
[TBL] [Abstract][Full Text] [Related]
10. MK-4101, a Potent Inhibitor of the Hedgehog Pathway, Is Highly Active against Medulloblastoma and Basal Cell Carcinoma.
Filocamo G; Brunetti M; Colaceci F; Sasso R; Tanori M; Pasquali E; Alfonsi R; Mancuso M; Saran A; Lahm A; Di Marcotullio L; Steinkühler C; Pazzaglia S
Mol Cancer Ther; 2016 Jun; 15(6):1177-89. PubMed ID: 26960983
[TBL] [Abstract][Full Text] [Related]
11. AT-101 inhibits hedgehog pathway activity and cancer growth.
Wang J; Peng Y; Liu Y; Yang J; Huang M; Tan W
Cancer Chemother Pharmacol; 2015 Sep; 76(3):461-9. PubMed ID: 26113054
[TBL] [Abstract][Full Text] [Related]
12. A five-gene hedgehog signature developed as a patient preselection tool for hedgehog inhibitor therapy in medulloblastoma.
Shou Y; Robinson DM; Amakye DD; Rose KL; Cho YJ; Ligon KL; Sharp T; Haider AS; Bandaru R; Ando Y; Geoerger B; Doz F; Ashley DM; Hargrave DR; Casanova M; Tawbi HA; Rodon J; Thomas AL; Mita AC; MacDonald TJ; Kieran MW
Clin Cancer Res; 2015 Feb; 21(3):585-93. PubMed ID: 25473003
[TBL] [Abstract][Full Text] [Related]
13. Targeting medulloblastoma: small-molecule inhibitors of the Sonic Hedgehog pathway as potential cancer therapeutics.
Romer J; Curran T
Cancer Res; 2005 Jun; 65(12):4975-8. PubMed ID: 15958535
[TBL] [Abstract][Full Text] [Related]
14. The hedgehog pathway and neurological disorders.
Dellovade T; Romer JT; Curran T; Rubin LL
Annu Rev Neurosci; 2006; 29():539-63. PubMed ID: 16776596
[TBL] [Abstract][Full Text] [Related]
15. Canonical Notch signaling is not required for the growth of Hedgehog pathway-induced medulloblastoma.
Julian E; Dave RK; Robson JP; Hallahan AR; Wainwright BJ
Oncogene; 2010 Jun; 29(24):3465-76. PubMed ID: 20418906
[TBL] [Abstract][Full Text] [Related]
16. Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice.
Romer JT; Kimura H; Magdaleno S; Sasai K; Fuller C; Baines H; Connelly M; Stewart CF; Gould S; Rubin LL; Curran T
Cancer Cell; 2004 Sep; 6(3):229-40. PubMed ID: 15380514
[TBL] [Abstract][Full Text] [Related]
17. Null mutation of DNA strand break-binding molecule poly(ADP-ribose) polymerase causes medulloblastomas in p53(-/-) mice.
Tong WM; Ohgaki H; Huang H; Granier C; Kleihues P; Wang ZQ
Am J Pathol; 2003 Jan; 162(1):343-52. PubMed ID: 12507917
[TBL] [Abstract][Full Text] [Related]
18. SHH inhibitors for the treatment of medulloblastoma.
Samkari A; White J; Packer R
Expert Rev Neurother; 2015; 15(7):763-70. PubMed ID: 26027634
[TBL] [Abstract][Full Text] [Related]
19. Medulloblastoma stem cells.
Fan X; Eberhart CG
J Clin Oncol; 2008 Jun; 26(17):2821-7. PubMed ID: 18539960
[TBL] [Abstract][Full Text] [Related]
20. Hitting the target in medulloblastoma therapy.
Bradbury J
Drug Discov Today; 2004 Dec; 9(23):994-5. PubMed ID: 15574311
[No Abstract] [Full Text] [Related]
[Next] [New Search]
